Business Wire

COYO-GMBH

20.7.2021 16:28:52 CEST | Business Wire | Press release

Share
COYO acquires French Employee Engagement Platform Jubiwee

COYO, the leading social intranet and employee communications platform, lands a coup with the acquisition of Paris-based people analytics platform Jubiwee. For the past 5 years Jubiwee has been doubling its operations and customer-base yearly. Over 40 French blue-chip companies use Jubiwee to assess staff motivation or to support transformation projects. In joining forces with Jubiwee, COYO accelerates its internationalization outside the DACH region and adds a critical toolkit to its digital workplace proposition.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210720005881/en/

Since the virus fast-tracked remote work, countless businesses have learned that their operational effectiveness in remote scenarios was heavily dependent on employee engagement. With Jubiwee's engagement analytics tools and their own communications and intranet platform, COYO now brings a complete employee engagement offering to the market. Customers will be enabled to address the limitations of remote work and make it more successful for employers and employees alike.

To ensure continuity and stability both company- and product-wise, Thibaud Martin, co-founder of Jubiwee, will join the COYO management team. Jubiwee’s office in Paris will become COYO’s French head office. Jubiwee customers have already been informed that their product of choice will be continued and even enhanced.

With the ambition to build ‘sexy and engaging business software’, Hamburg-based tech entrepreneur Jan Marius Marquardt founded COYO in 2010. The current platform is a modern social intranet and employee app that empowers organizations to drive employee engagement and improve workplace culture. The platform has over 400 customers, serving more than 1 million end-users. Jan Marius Marquardt, founder and CEO of COYO, says: “I am beyond happy about joining forces with Jubiwee: It feels like the right step, pushing the company and product to the next level and accelerate our expansion to France, one of our priority markets. Beyond cool technology there is no better way to start building up a French presence than by teaming up with a French team that has already proven successful and shares our values. This addition is a next big step towards becoming the most widely adopted employee communications platform in the world.”

Both companies have European DNA, share the same culture and vision and are very product-focused: UX and UI are critical, while user adoption is above-market. Jubiwee’s tech and UX-centered product resonates strongly with COYO’s product philosophy. Jan Marius Marquardt explains: “A capable engagement analytics solution is instrumental in a truly 360° employee communications offering and will bring a lot of value to customers. The merger thus presents an excellent opportunity for both current German and French customers.”

Jubiwee was founded in 2016 by Thibaud Martin, Victor Mustar, and Antoine Bellion. The company offers a new generation engagement analytics platform with a user-centric approach to improve employee experience, reduce turnover and improve retention. Thibaud Martin, co-founder, and CEO of Jubiwee, explains: “The people analytics and overall employee engagement market has grown tremendously in recent months, partly due to the COVID-crisis. Also, customers have grown more mature and demanding. To capitalize on this shift, we decided to partner with a strong, renowned, and ambitious company that shares the same values: COYO. Joining forces with COYO is the best way to build a more comprehensive offer and accelerate at this crucial time.”

Both solutions will be continued in their current form and developed according to their respective roadmaps. Short-term ambitions include continuing Jubiwee’s growth in France, cross-selling respective solutions to existing customers and prospects as well as introducing the COYO offer in France. Mid and long-term ambitions include integrating both solutions to offer a complete employee engagement suite, enabling companies to communicate, and take the pulse of their coworkers in a modern, efficient and seamless way. Overall, the companies’ solutions are complementary and together present a strong offering, both in terms of depth and breadth. By adding two very competent best-of-breed solutions, COYO and Jubiwee are creating one extremely compelling suite.

More information is available at www.coyoapp.com .

Link:

ClickThru

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

2PointZero Group Signals Global Scale With Revenue Surge to AED 21.9 Billion and Net Profit of AED 7.7 Billion in H1 202631.7.2026 13:42:00 CEST | Press release

Group revenue growth supported by stable gross profit margin of 29%, and adjusted EBITDA of AED 5.0 billionGlobal expansion milestones include the completed sale of TAQA stake, and the acquisition of Traverse Midstream Partners in North America, Baobab Group in Africa, and 60.8% of ISEM in ItalyTIME ranks the Group 36th on the World’s Growth Leaders list for 2026, highlighting market stability, operational scale and disciplined approach to capital 2PointZero Group (ADX: 2POINTZERO), a leading Abu Dhabi-based investment holding firm, announced its financial results for the first half of 2026, reporting revenue of AED 21.9 billion and delivering a Group Net Profit of AED 7.7 billion. This robust performance is reflected in the Group’s adjusted EBITDA, which reached AED 5.0 billion after excluding fair value changes and one-offs. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260731538982/en/ Samia Bouazza, CEO of 2PointZero (P

Datroway® Approved in the EU as Only TROP2 Directed Medicine with Overall Survival Benefit for the First-Line Treatment of Patients with Metastatic TNBC Who Are Not Candidates for Immunotherapy31.7.2026 08:30:00 CEST | Press release

Approval based on TROPION-Breast02 phase 3 trial results where Daiichi Sankyo and AstraZeneca’s Datroway showed a statistically significant and clinically meaningful improvement for the dual primary endpoints of overall survival and progression-free survival Datroway now approved for two breast cancer indications in the EU Datroway® (datopotamab deruxtecan) has been approved in the European Union (EU) as monotherapy for the first-line treatment of adult patients with unresectable or metastatic triple negative breast cancer (TNBC) who are not candidates for PD-1/PD-L1 inhibitor therapy. Datroway is a specifically engineered TROP2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The approval by the European Commission follows the positive opinionof the Committee for Medicinal Products for Human Use of the European Medicines Agency and is based on result

Polpharma Biologics Announces FDA and EMA Acceptance for Review of PB016 Vedolizumab Biosimilar Candidate31.7.2026 08:30:00 CEST | Press release

Polpharma Biologics International AG today announces that the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) have accepted for review the Biologics License Application (BLA) and Marketing Authorisation Application (MAA), respectively, for PB016, a proposed vedolizumab biosimilar candidate to Takeda’s reference product Entyvio®* (vedolizumab) lyophilized vial for intravenous (IV) administration for the treatment of adults with moderately to severely active ulcerative colitis and Crohn's disease. The BLA and MAA acceptances represent significant milestones in Polpharma Biologics' development program and underscore the company's commitment to advancing high-quality biosimilars and expanding global access to affordable biologic medicines. "FDA and EMA acceptances for review of our IV vedolizumab biosimilar candidate mark a major achievement for Polpharma Biologics and validate our deep scientific expertise in biosimilar development and manufacturing," said

SES: Disclosure of Share Buyback Transactions31.7.2026 07:30:00 CEST | Press release

In the time period from June 2, 2026 until and including June 23, 2026, a number of 213,167 shares were bought back within the framework of the share buyback of SES to meet obligations under SES’s Equity Based Compensation Plan (EBCP). Shares were bought back as follows: Day of purchase Aggregated volume in shares Daily weighted average acquisition price of shares (EUR) Market June 2, 2026 27,097 8.8727 DXE June 2, 2026 72,903 8.8556 ENX June 5, 2026 16,624 8.3723 DXE June 5, 2026 31,510 8.4266 ENX June 15, 2026 26,451 7.8423 XPAR June 17, 2026 26,812 7.3910 XPAR June 23, 2026 11,770 7.2200 XPAR The transactions in a detailed form are published on SES’s website: https://www.ses.com/investors/shareholder-information/share-buy-backs. Follow us on: Twitter | Facebook | YouTube | LinkedIn | Instagram Read our Blogs > Visit the Media Gallery > About SES At SES, we believe that space has the power to make a difference. That’s why we design space solutions that help governments protect, busin

Half-Year Report on SES’s Liquidity Contract31.7.2026 07:30:00 CEST | Press release

Pursuant to the liquidity contract entered into by SES with BNP Paribas as of 7 April 2026, please see the below update on the progress of the liquidity services. When the liquidity services were implemented as of 7 April 2026, the following assets were in the liquidity account: € 2,500,000 As of 30 June 2026, the following assets appeared on the liquidity account: 228,186 shares; € 816,880. Over the period from 7 April 2026 to 30 June 2026, the following transactions were executed: 1,082 buy transactions; 1,308 sales transactions. Over this same period, the volumes traded represented: 1,093,335 shares and € 8,485,986 on the buy side; 873,399 shares and € 6,860,843 on the sell side. Follow us on: LinkedIn | Facebook | YouTube | X | Instagram Read our Blogs > Visit the Media Gallery > About SES At SES, we believe that space has the power to make a difference. That’s why we design space solutions that help governments protect, businesses grow, and people stay connected—no matter where th

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye